glp-1 agonists names GI Adverse Effects of Glucagon-Like Peptide-1 Receptor glp 1 receptor agonists brand

Williams RA, Roe LS, Rolls BJ

Prior to that, the treatment of obesity has been predominantly limited to lifestyle interventions and bariatric surgery

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)a multicentre, double-blind, randomised, placebo-controlled trial

Falkn Y, Hellstrm PM, Holst JJ, Nslund E

Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years

This could be due to existing medical reasons or a history of illness with your family